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INTRODUCTION AND OBJECTIVES
The last 15 years has brought growing concern among the general public, policy makers, and environmental scientists over the unknown consequences of pharmaceuticals and antimicrobials in the environment. They have been found in streams and rivers throughout the United States (Kolpin et al. 2002) . It is widely believed that the primary source of these compounds in streams is discharge from wastewater treatment plants (WWTPs). Wastewater from industrial facilities which manufacture these compounds as well as hospital and domestic wastewaters are considered to be major contributors of these compounds to WWTPs (M.D. Hernando 2006) . Since the major pathway of these compounds to the environment is through WWTPs, the release of these compounds to the environment ultimately depends on the ability of WWTPs to remove these compounds from wastewater. However, not all WWTPs use the same treatment technologies or have the same influent wastewater characteristics; therefore, the ability of WWTPs to remove these compounds may depend on the type of treatment being used and/or the characteristics of the wastewater.
Two common wastewater treatment technologies used in the U.S. are activated sludge and trickling filter treatment. When operated properly, both technologies are capable removing regulated constituents such as biochemical oxygen demand (BOD), suspended solids (TSS), and ammonia-nitrogen. However, the ability of activated sludge and trickling filters to remove certain pharmaceuticals and antimicrobials is not well understood. In fact, very little is known about removal of these compounds during wastewater treatment and associated treatment of sludge generated during treatment.
The pharmaceuticals and antimicrobials chosen for this study were acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole, triclosan, and trimethoprim (Table 1 .1 and Figure 1 .1). These compounds were among the 30 most frequently detected compounds in the Kolpin et al. (2002) study where reported concentrations ranged from approximately 0.01 to 10 µg/L. Acetaminophen, caffeine, and ibuprofen are nonprescription drugs. 1,7-dimethylxanthine is a metabolite of caffeine and cotinine is a metabolite of nicotine. Triclosan is an antibacterial agent used in many personal care products (Canosa et al. 2005) . Sulfamethoxazole and trimethoprim are antibiotics prescribed to treat infectious diseases in both humans and animals (Perez et al. 2005) . Typically sulfamethoxazole and trimethoprim are administered together to overcome the increase in bacterial resistance to sulfamethoxazole (Drillia et al. 2005) .
Most literature reports describe the removal of these compounds over the entire treatment plant (i.e., plant effluent compared to raw wastewater concentrations) although some report on specific removals by activated sludge and trickling filtration. Caffeine is readily removed during wastewater treatment with Perez et al. (2005) reporting complete removal of 37 µg/L and Thomas and Foster (2005) reporting greater than 99% removal of approximately 43 µg/L. Reported removals of ibuprofen by activated sludge WWTPs were 40% to greater than 90%, yielding effluent concentrations of 0.01 to 0.2 µg/L (Castiglioni et al. 2006; Han et al. 2006; Paxeus 2004; Tauxe-Wuersch et al. 2005; Thomas and Foster 2005; Yu et al. 2006) . Reported removals of acetaminophen were 9% to greater than 99% (Han et al. 2006; Yu et al. 2006) . Batch experiments conducted by Yu et al. (2006) showed complete removal of 50 µg/L of ibuprofen and acetaminophen within 14 days.
There is significantly more data on the fate of triclosan during wastewater treatment. Reported influent concentrations range from 0.8 to 17 µg/L, with effluent concentrations of 0.03 to 0.25 µg/L (McAvoy et al. 2002; Singer et al. 2002; Waltman et al. 2006; Yu et al. 2006) . Removals at full-scale WWTPs ranged from 69 to 99%, with most removal occurring during biological treatment (Federle et al. 2002; McAvoy et al. 2002; Singer et al. 2002; Waltman et al. 2006; Yu et al. 2006) . Separate batch experiments with activated sludge showed complete removal of 1 to 50 µg/L in 50 days (Yu et al. 2006 ). Federle et al. (2002) showed that 81 to 92% of added triclosan was mineralized to CO 2 or incorporated into biomass after 50 days. McAvoy et al. (2002) found activated sludge treatment to be more effective with a removal efficiency over 95% compared to a removal efficiency of 58% to 86% during trickling filter treatment.
Limited data indicates that trimethoprim is more completely removed than sulfamethoxazole in conventional wastewater treatment. Reported removals of trimethoprim were 77% to greater than 90%, with effluent concentrations of 0.05 to 0.1 µg/L (Gobel et al. 2005; Paxeus 2004; Perez et al. 2005) . Removals of sulfamethoxazole are reported to be 17 to 71%, with effluent concentrations of 0.3 to 0.9 µg/L (Castiglioni et al. 2006; Gobel et al. 2005; Perez et al. 2005) . The relatively low level of removal for some pharmaceuticals and antimicrobials, particularly for sulfamethoxazole, has led researchers to consider alternative treatment approaches to better safeguard the environmental and protect human health.
Constructed Wetlands for the Removal of

Sulfamethoxazole and Trimethoprim
Three main types of engineered wetlands are typically used to treat wastewater including: free water surface (FWS), vertical flow (VF) and horizontal subsurface-flow (HSSF) (Kadlec and Wallace 2009 ). FWS wetlands are many times undesirable in populated areas where the growth of mosquitos and other flying insects would be a nuisance and increase the risk of negative human health outcomes. VF wetlands can typically remove higher levels of BOD 5 , but they are also more expensive to operate due to increased pumping costs. Our research utilized HSSF treatment wetlands which can be vegetated and further insulated for use in cold climates with an organic rich mulch layer above the gravel treatment layer (Kadlec and Wallace 2009; Werker et al. 2002) .
Studies on the removal of pharmaceuticals and antimicrobials showed that HSSF wetlands can remove many compounds of interest, even in cold climates. A treatment study in Mandeville, Louisiana utilized a series of aerations lagoons followed by a FWS wetland and then by an ultraviolet disinfection system showed reduction of almost all compounds of interest, including sulfamethoxazole, by greater than 90 percent. (Conkle et al. 2008) .
Another study measured the mass discharge rate, into the River Besòs in Spain, for 12 pharmaceutical and personal care products from a typical. A one-hectare FWS wetland at the site showed removal efficiencies greater than 90 percent for 8 of the contaminants. The greater removal seen in the summer was likely caused by increased photo-and microbial degradation due to sun exposure and higher water temperatures. (Matamoros et al. 2008) A similar study compared the use of two "Filtralite-P" units, two biological sand filters, five HSSF and four VF wetlands. Removal efficiencies for total suspended solids and BOD 5 were similar in all systems and pharmaceuticals were greater than 80 percent removed. The vegetated VF wetland showed the best overall performance (Matamoros et al. 2009 ).
It is suspected that deep rooted plants in HSSF treatment wetlands effect treatment by creating additional surface area for biofilm, by facilitating oxygen transfer, 
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The use of cyclic aeration in constructed wastewater treatment wetlands is a newer concept that significantly improves removal of TSS, BOD 5 and nitrogen (Kadlec and Wallace 2009 ). The impact of cyclic aeration on the removal of sulfamethoxazole and trimethoprim has not been fully studied. In a comparison of 4 wastewater treatment plants with varying designs and operations, typical aeration levels showed little effect on the removal of sulfamethoxazole (Batt et al. 2007 ). But, sulfamethoxazole and trimethoprim were significantly removed in a pure oxygen primary treatment aeration system and during extended aeration secondary treatment. The pure oxygen system, which reportedly can handle a greater organic loading rate, had an HRT of only 1 hour but significantly removed sulfamethoxazole and trimethoprim. The extended aeration secondary treatment operations had HRTs of 28-31 hours. One system with two aeration stages had solids retention times (SRT) of 6 days and 49 days with the authors suggesting that long SRTs favor the development of nitrifying bacteria that degrade trimethoprim (Batt et al. 2007 ).
This review indicates that limited data are available regarding the occurrence and fate of pharmaceutical and antimicrobial chemicals during wastewater collection and treatment. The objectives of this study were to 1) track acetaminophen, caffeine, 1,7dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole, triclosan, and trimethoprim through various stages of activated-sludge and trickling-filter WWTPs; 2) to measure these compounds in hospital, domestic, and industrial wastewaters; 3) to make these measurements during different seasons of the year, with the goal of better understanding the behavior of these compounds during wastewater collection and treatment and 4) determine the ability of horizontal, subsurface-flow treatment wetlands to remove sulfamethoxazole and trimethoprim from wastewater prior to discharge. The treated wastewater is chlorinated with hypochlorite, and then dechlorinated with sulfur dioxide before discharge to the Iowa River. Samples were collected with PVC bailers then transferred (for manholes) or collected directly (at the WWTPs) in 950 mL amber, glass bottles. Latex gloves were worn during, and changed after, each collection and samples were stored at 4°C for no longer than 7 days prior to analysis preparation. The hospital wastewaters discharged to a branch of the collection network connected to the NTF WWTP. The wastewaters from the domestic area and the industrial facility were treated by the NAS WWTP.
Sample Preparation and Quantification: Solid phase extraction (SPE) was used to concentrate target compounds from wastewater. Samples were gravity settled in clean, glass beakers and then two ml of 0.5 M ammonium carbonate was added to 100 ml of the supernate in a separate, clean beaker. Oasis HLB SPE cartridges (Waters, Inc.) were conditioned sequentially with 10 ml ethyl acetate, 10 ml methanol, and 10 ml ammonium carbonate (10 mM). The supernate was vacuumed through a SPE cartridge followed by 5 mL of beaker rinsate (10 mM ammonium bicarbonate). The cartridge was rinsed with 5 mL deionized water, under vacuum, before gravity elution with 15 mL ethyl acetate. The extract was evaporated to 0.5 mL with pure, dry nitrogen then transferred to a vial containing 0.1 mL acetonitrile and 0.4 ml deionized water. 
Treatment Wetland Studies
Pilot-scale, HSSF wetlands at the Iowa City South Wastewater Treatment Plant (Iowa City, Iowa) were operated for this study. The treatment wetlands consisted of duplicate cells with 4 different treatments: (1) A bromide tracer test was conducted to assess the hydraulic characteristics of each wetland cell (Redmond et al. 2012 ). Potassium bromide (182 g Br -) was added to each cell and samples were collected at the effluent daily for 12 days. Bromide concentrations were determined by ion selective electrode (Thermo Scientific; Waltham, MA).
Sampling, Preparation and Analysis of Sulfamethoxazole and Trimethoprim for
Quantification: Influent and effluent samples were collected on three separate occasions representing internal wetland temperatures of 6, 9 and 24 degrees Celsius. An additional, cross-sectional sampling was performed at 2, 4, and 6 feet from the influent side of the wetland, along the water flow path. Samples (100 mL) for sulfamethoxazole and trimethoprim were collected in methanol rinsed glass bottles and then filtered with 0.45 glass microfiber filters. The samples collected at 24 C were prepared via solid phase extraction to a final volume of 10 mL using Oasis 6 mL, 500 mg HLB SPE cartridges (Waters) conditioned with 6 mL of ACN followed by 6 mL of DI water. Prior to extraction, Na 2 EDTA was added and the pH was lowered to 2.5-3 with hydrochloric acid.
The analytes were eluted with 2 separate, 4 mL aliquots of ACN followed by 2 
CHAPTER 3
RESULTS AND DISCUSSION
Wastewater Characterization
Acetaminophen, caffeine, cotinine, ibuprofen, sulfamethoxazole, triclosan, and trimethoprim were found in the hospital and the domestic wastewater collection networks, but the industrial wastewater contained only acetaminophen and caffeine (Figure 3.1) . The acetaminophen and caffeine in the industrial wastewater was likely human-waste derived since manufacturing processes at the facility do not utilize these compounds. The hospital wastewaters contained the greatest concentrations of measured compounds including acetaminophen and caffeine concentrations above 100,000 ng/L.
Since sulfamethoxazole and trimethoprim are routinely prescribed in tandem they were, not surprisingly, found at similar concentrations in all samples. The domestic wastewater contained relatively high amounts of each measured compound with concentrations above 1,000 µg/L for acetaminophen, caffeine and ibuprofen (Woods 2006) .
Removal During Conventional Wastewater Treatment
Acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole, triclosan, and trimethoprim were detected in the NAS WWTP influent wastewater in the month of December (Figure 3 .2). Acetaminophen was measured at 140,000 ng/L, caffeine was 39,000 ng/L and ibuprofen was 12,000 ng/L. The influent sulfamethoxazole concentration was 2,000 ng/L while triclosan and trimethoprim concentrations were each found to be 700 ng/L (Woods 2006) .
The aqueous concentrations of acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, and triclosan in the final effluent were significantly less than the plant influent concentrations (Figure 3 .2). Sulfamethoxazole was removed to a lesser extent and trimethoprim was not removed at all. The final effluent concentrations for acetaminophen, cotinine and caffeine were below 20 ng/L, representing a greater than 99% removal. The final effluent concentrations of 1,7-dimethylxanthine, ibuprofen and triclosan were below 100 ng/L, representing a greater than 90% removal. The NAS WWTP removed 83% of the influent sulfamethoxazole with a measured final effluent concentration of 340 ng/L. Trimethoprim was not removed as evidenced by a consistent aqueous concentration near 700ng/L measured at each unit operation.
Acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, triclosan, and sulfamethoxazole were mostly removed by the NAS unit operation. Slight removal was observed during primary clarification for acetaminophen, cotinine, ibuprofen, and sulfamethoxazole.
Acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole, and trimethoprim were found in the NTF WWTP influent wastewater in the month of February (Figure 3 .3). The acetaminophen concentration was 123,000 ng/L, caffeine was 97,000 ng/L, cotinine was 900 ng/L and 1,7-dimethylxanthine was 16,000 ng/L. The influent concentration of ibuprofen was 5,800 ng/L, sulfamethoxazole was 2,000 ng/L and trimethoprim was 1,000 ng/L. Triclosan was not detected in the influent wastewater, but it was found in the primary effluent, trickling filter effluent and final effluent. The daily average NTF WWTP influent wastewater pH of 7.5, which is very near the pKa of triclosan (7.9), likely left only a fraction of the total triclosan in the quantifiable, protonated form. Samples collected later in the treatment process were at lower average pH (7.2) making triclosan detection more likely.
The aqueous concentrations of acetaminophen, caffeine, 1,7-dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole and trimethoprim in the final effluent were significantly less than concentrations in the plant influent (Table 3 .1). Acetaminophen was reduced 99%; caffeine decreased 92%; cotinine was reduced 56%; 1,7dimethylxanthine decreased 84%; ibuprofen decreased 76%; sulfamethoxazole was reduced 45% and trimethoprim was reduced 30%.
The average influent/effluent concentration from four NAS WWTP sample events was compared to data for one NTF WWTP sampling event to determine the comparative, target compound removal efficiencies (Table 3 .2). The NAS WWTP showed greater than 97% removal for all target compounds except sulfamethoxazole and trimethoprim, which were minimally removed or not removed at all. The NTF WWTP removed 99% of the acetaminophen, but unlike the NAS WWTP, the concentration of sulfamethoxazole and trimethoprim were reduced significantly (45% and 30%, respectively).
Removal of Sulfamethoxazole and Trimethoprim by
Treatment Wetlands
The removal of sulfamethoxazole ranged from 45 to 89 percent across all temperatures studied (Table 3 .3 and Figure 3 .4, Figure 3 .5, and Figure 3 .6). There was no apparent correlation between removal and temperature as confirmed by the OW-RM ANOVA analysis (P>0.05). Trimethoprim was removed at greater than 96 percent regardless of temperature or any combination of wetland vegetation or wetland aeration.
Therefore, all treatments were statistically similar for trimethoprim (RM ANOVA-R, P>0.05).
Vegetation played no significant role in the removal of sulfamethoxazole at the loading rates used in this study. Aeration was also an insignificant factor in sulfamethoxazole removal despite the measured increase in concentration in the aerated | unplanted treatment at 24 degrees C. The creation of sulfamethoxazole during wastewater treatment has been reported to result from the transformation of the human sulfamethoxazole metabolite, N 4 -acetylsulfamethoxazole (Conkle et al. 2008; Gobel et al. 2007 ). But, the transformation of N 4 -acetylsulfamethoxazole to sulfamethoxazole would be expected mostly under reducing conditions and not so much in an aerated wetland treatment cell as shown by our data.
Results of the cross-sectional sampling study (Figure 3 .7) showed that sulfamethoxazole concentrations were somewhat variable at 2, 4 and 6 feet with most of the removal occurring between 2 and 4 feet. This result could be viewed as inconclusive since the sulfamethoxazole concentration actually increased in the first two feet of travel distance. The trimethoprim concentration remained mostly stable in the first two feet, but was almost completely removed before 4 feet. Influent sulfamethoxazole was 1300, 1300, and 340 ng/L for the 6, 9 and 24 C sample sets respectively. Influent trimethoprim was 1200, 550, and 320 ng/L for the 6, 9 and 24 C sample sets respectively. 
CHAPTER 4 CONCLUSIONS
The results of this study demonstrate a comparison of a NAS WWTP, a NTF WWTP, and a horizontal, subsurface-flow wastewater treatment wetland and their ability to remove pharmaceuticals and antimicrobials prior to discharge to surface water. The pharmaceuticals and antimicrobials of interest; acetaminophen, caffeine, 1,7dimethylxanthine, cotinine, ibuprofen, sulfamethoxazole, triclosan, and trimethoprim;
were detected in all stages of the NAS WWTP, the NTF WWTP, and in the hospital waste stream, with the exception of tricolsan in the influent of the NTF WWTP.
However, only acetaminophen and caffeine were detected in the industrial waste stream, which was likely the result of human excretion. The NAS WWTP removed acetaminophen, cotinine, and caffeine with a removal efficiency of greater than 99% and 1,7-dimethylxanthine, ibuprofen, and triclosan resulted in greater than 90% removal. In the NAS WWTP sulfamethoxazole was hardly removed while trimethoprim had no removal. The NTF WWTP removed acetaminophen by 99%, caffeine by 92%, cotinine by 56%, 1,7-dimethylxanthine by 84%, ibuprofen by 76% and variant from the NAS WWTP sulfamethoxazole and trimethoprim were remove by 45% and 30% respectively.
Sulfamethoxazole and trimethoprim were the compounds tested for removal in the horizontal, subsurface-flow wastewater treatment wetland with aeration, planting and temperature as the treatments applied to the waste stream. The results showed no statistically significant relationship between the removal of each compound and the treatments applied. Sulfamethoxazole removal ranged from 45-89 percent and trimethoprim was removed greater than 96 percent. The aerated subsurface flow wetlands offer a significantly higher removal of sulfamethoxazole and trimethoprim than the NAS WWTP and the NTF WWTP. The data from the wetland indicates the removal is due to a greater HRT in the wetland than in a typical WWTP.
